From: Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control
Patients (total 67) (number and %) | Features |
---|---|
Anti HCV antibodies | 67/67 (100%) |
Chronic Hepatitis | 67/67 (100%) |
Cirrhosis | 6/67 (8.9%) |
Presumed disease duration (years) | 6.1 ± 2.7 |
Fibrosis score | 1.9 ± 0.7 |
HAI score [47] | 6.5 ± 1.2 |
HCV genotype (number and %) | |
 1 | 43 (64.1%) |
 2 | 1 (1.5%) |
 3 | 21 (31.3%) |
 4 | 2 (3%) |